[Click here to learn more about the class action] On this news, the price of Teladoc shares declined by $4.85 per share, or approximately 23.7%, from $20.49 per share on February 20, 2024 to close at $15.64 on February 21, 2024. If you purchased or otherwise acquired Teladoc securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out this CONTACT FORM, to discuss your rights ...

Teladoc Health, Inc. (TDOC) recently showcased data from two studies at the American Diabetes Association's 84th Scientific Sessions. These studies highlight Teladoc's predictive modeling capabilities in aiding members with type 2 diabetes to manage their blood sugar levels through its diabetes management program. Following the news, the stock gained 6.7% yesterday. Leveraging AI is helping the company with digital interventions, while keeping the human touch in member interactions, leading to better health ...

Teladoc (TDOC) shares soared 6.7% in the last trading session to close at $10.36. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.4% loss over the past four weeks. For Teladoc, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on TDOC going forwar ...

NEW YORK, June 25, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Teladoc Health, Inc. (NYSE: TDOC). Shareholders who purchased shares of TDOC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: CLASS PERIOD: November 2, 2022 to February 20, 2024 DEADLINE: July 16, 2024 Shareholders should not delay in registering for ...

PURCHASE, NY, June 24, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in whole-person virtual care, released new data today from two studies, presented at the American Diabetes Association's 84th Scientific Sessions, that illustrate the company's unmatched predictive modeling capabilities to help members with type 2 diabetes control their blood sugar through participation in Teladoc Health's diabetes management program. The new data shows a 3X increase in engagement leading to an add ...

PURCHASE, NY, June 21, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in whole-person virtual care, is providing free, 24/7 general medical telehealth visits to New Mexico residents, first responders and others directly impacted by the devastating wildfires. Individuals in New Mexico who have been displaced or who cannot access medical care as a result of the fires can seek treatment from a licensed health care professional for any non-emergency illness by calling Teladoc Health dire ...

PURCHASE, NY, June 21, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in whole-person virtual care, is providing free, 24/7 general medical telehealth visits to New Mexico residents, first responders and others directly impacted by the devastating wildfires. Among those adult and pediatric conditions that can be effectively diagnosed and treated as part of Teladoc Health's general medical no-cost offering are common conditions including urinary tract infections, sinus problems, respi ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of Teladoc Health, Inc. (NYSE: TDOC) between November 2, 2022 and February 20, 2024, both dates inclusive (the "Class Period"), of the important July 16, 2024 lead plaintiff deadline. WHAT TO DO NEXT: To join the Teladoc class action, go to https://rosenlegal.com/submit-form/? case_id=6818 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action laws ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of Teladoc Health, Inc. (NYSE: TDOC) between November 2, 2022 and February 20, 2024, both dates inclusive (the "Class Period"), of the important July 16, 2024 lead plaintiff deadline. What to do next: To join the Teladoc class action, go to https://rosenlegal.com/submit-form/?case_id=6818 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit ...

Shareholders who purchased shares of TDOC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: November 2, 2022 to February 20, 2024 NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of TDOC during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout t ...